Peptide Therapeutics Market by Route of Administration (Parenteral, Oral, and Others), by Type (Innovative and Generic), by Type of Manufacturers (In-house and Outsourced), by Type of Molecule (Vasopressin, Somatostatin, Calcitonin, Immunopeptide, Natriuretic, and Others), by Technology (Liquid Phase, Solid Phase, and Hybrid Phase), and by Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, and Others)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020 – 2029

                                          
Abstract
                    
The report covers forecast and analysis for the peptide therapeutics market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints for the peptide therapeutics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the peptide therapeutics market on a global level.

In order to give the users of this report a comprehensive view of the peptide therapeutics market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service type launch, agreements, partnerships, collaborations & joint ventures, research & development, service type, and regional expansion of major participants involved in the market.

The study provides a decisive view on the peptide therapeutics market by segmenting it on the route of administration, type, type of manufacturers, type of molecule, technology, application, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further categorization into major countries including the U.S., the UK, Germany, France, China, Japan, India, Brazil, etc. This segmentation includes demand for peptide therapeutics market based on all segments in all the regions and countries.

The key players in the global peptide therapeutics market are Amgen Inc., Pfizer Inc., Eli Lilly and Company, Teva Pharmaceuticals Industries Ltd., Lonza Inc., Takeda Pharmaceutical Company Limited, Bristol-Myers Squibb, Sanofi, AstraZeneca PLC, and Novartis AG.

This report segments the global peptide therapeutics market as follows:

Global Peptide Therapeutics Market: Route of Administration Segment Analysis

	Parenteral
	Oral
	Others

Global Peptide Therapeutics Market: Type Segment Analysis

	Innovative
	Generic

Global Peptide Therapeutics Market: Type of Manufacturers Segment Analysis

	In-house
	Outsourced

Global Peptide Therapeutics Market: Type of Molecule Segment Analysis

	Vasopressin
	Somatostatin
	Calcitonin
	Immunopeptide
	Natriuretic
	Others

Global Peptide Therapeutics Market: Technology Segment Analysis

	Solid Phase
	Liquid Phase
	Hybrid Phase

Global Peptide Therapeutics Market: Application Segment Analysis

	Cancer
	Cardiovascular Disease
	Metabolic Disease
	Respiratory Disease
	Infectious Disease
	Others

Global Peptide Therapeutics Market: Regional Segment Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa